RAVEN Biotechnologies' Series C Round

RAVEN Biotechnologies raised a round of funding on January 09, 2003.

Raven biotechnologies is a privately held biotechnology company focused on the simultaneous discovery of novel cell surface drug targets and the antibody therapeutics to regulate them. Raven's integra…

Articles about RAVEN Biotechnologies' Series C Round: